Home » Stocks » XTNT

Xtant Medical Holdings, Inc. (XTNT)

Stock Price: $1.58 USD 0.10 (6.76%)
Updated Jan 25, 2021 4:00 PM EST - Market closed
Market Cap 113.75M
Revenue (ttm) 56.29M
Net Income (ttm) -7.92M
Shares Out 13.23M
EPS (ttm) -0.61
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 25
Last Price $1.58
Previous Close $1.48
Change ($) 0.10
Change (%) 6.76%
Day's Open 1.51
Day's Range 1.48 - 1.60
Day's Volume 222,471
52-Week Range 0.62 - 1.74

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 month ago

BELGRADE, Mont., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of sp...

Seeking Alpha - 2 months ago

Xtant Medical Holdings, Inc. (XTNT) CEO Sean Browne on Q3 2020 Results - Earnings Call Transcript

GlobeNewsWire - 2 months ago

BELGRADE, Mont., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of sp...

GlobeNewsWire - 3 months ago

BELGRADE, Mont., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of sp...

GlobeNewsWire - 3 months ago

BELGRADE, Mont., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of sp...

GlobeNewsWire - 3 months ago

BELGRADE, Mont., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of sp...

InvestorPlace - 3 months ago

Xtant Medical Holdings news on Friday has XTNT stock skyrocketing after the company announced the completion of their debt restructuring plan. The post XTNT Stock Skyrockets After Xtant Medica...

GlobeNewsWire - 3 months ago

BELGRADE, Mont., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of sp...

GlobeNewsWire - 5 months ago

BELGRADE, Mont., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of ...

PRNewsWire - 5 months ago

PHILADELPHIA, Aug. 15, 2020 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Xtant Medical Holdings, Inc.

GlobeNewsWire - 5 months ago

BELGRADE, Mont., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of ...

Seeking Alpha - 5 months ago

Xtant Medical Holdings, Inc. (XTNT) CEO Sean Browne on Q2 2020 Results - Earnings Call Transcript

GlobeNewsWire - 5 months ago

BELGRADE, Mont., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of ...

GlobeNewsWire - 5 months ago

BELGRADE, Mont., July 30, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of ...

Seeking Alpha - 8 months ago

Xtant Medical Holdings, Inc. (XTNT) CEO Sean Browne on Q1 2020 Results - Earnings Call Transcript

Seeking Alpha - 10 months ago

Xtant Medical Holdings, Inc. (XTNT) CEO Sean Browne on Q4 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Xtant Medical Holdings' (XTNT) CEO Sean Browne on Q3 2019 Results - Earnings Call Transcript

GlobeNewsWire - 1 year ago

BELGRADE, Mont., Oct. 18, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of ...

GlobeNewsWire - 1 year ago

BELGRADE, Mont., Sept. 18, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of...

Seeking Alpha - 1 year ago

Xtant Medical Holdings, Inc. (XTNT) Management on Q2 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Xtant Medical Holdings, Inc. (XTNT) Q1 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Xtant Medical Holdings' (XTNT) Management on Q4 2018 Results - Earnings Call Transcript

About XTNT

Xtant Medical Holdings develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DMB Putty for use as a bone void filler and bon... [Read more...]

Industry
Medical Devices
CEO
Sean Browne
Employees
141
Stock Exchange
NYSEAMERICAN
Ticker Symbol
XTNT
Full Company Profile

Financial Performance

In 2019, XTNT's revenue was $64.68 million, a decrease of -10.42% compared to the previous year's $72.20 million. Losses were -$8.22 million, -88.27% less than in 2018.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for XTNT stock is "Hold" and the 12-month stock price forecast is 1.00.

Price Target
$1.00
Analyst Consensus: Hold